Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Sales | 10,021,400 | 8,281,300 | 7,477,700 | 7,230,200 | 6,950,000 |
| Cost of Goods | 2,164,100 | 1,918,600 | 1,772,000 | 2,024,300 | 2,200,600 |
| Gross Profit | 7,857,300 | 6,362,700 | 5,705,700 | 5,205,900 | 4,749,400 |
| Operating Expenses | 5,558,200 | 4,390,800 | 4,040,400 | 3,762,800 | 3,496,500 |
| Operating Income | 2,299,200 | 1,972,500 | 1,665,300 | 1,443,400 | 1,253,500 |
| Interest Expense | 0 | 126,900 | 106,500 | 103,400 | 430,100 |
| Other Income | 0 | 15,900 | -707,400 | 194,800 | 120,300 |
| Pre-tax Income | 2,299,200 | 1,861,500 | 851,400 | 1,534,800 | 943,700 |
| Income Tax | 738,000 | 558,500 | 191,300 | 438,600 | 218,400 |
| Net Income Continuous | 1,551,600 | 1,298,400 | 1,183,688 | 1,072,200 | 722,295 |
| Net Income Discontinuous | 18,700 | 0 | 0 | -282,600 | 0 |
| Net Income | $1,572,900 | $1,298,400 | $657,500 | $810,900 | $722,100 |
| EPS Basic Total Ops | 0.42 | 0.35 | 0.17 | 0.21 | 0.18 |
| EPS Basic Continuous Ops | 0.41 | 0.35 | 0.31 | 0.27 | 0.18 |
| EPS Basic Discontinuous Ops | 0.01 | N/A | N/A | -0.07 | N/A |
| EPS Diluted Total Ops | 0.42 | 0.35 | 0.17 | 0.21 | 0.18 |
| EPS Diluted Continuous Ops | 0.41 | 0.35 | 0.31 | 0.27 | 0.18 |
| EPS Diluted Discontinuous Ops | 0.01 | N/A | N/A | -0.07 | N/A |
| EBITDA(a) | $2,673,200 | $2,264,500 | $1,923,500 | $1,707,300 | $1,497,600 |